A Creighton University oncologist is critical of an announcement by the United States Preventive Services Task Force about PSA-based screenings.
The Task Force announced this afternoon its recommendation against prostate-specific antigen or PSA-based screenings for all men regardless of age. Dr. Henry Lynch is the Director of the Hereditary Cancer Center at Creighton.
An estimated three of every 100 cases of colon cancer are the result of a hereditary genetic condition called Lynch Syndrome.
Thursday is Lynch Syndrome Awareness Day. It’s named for Dr. Henry Lynch, the Director of Creighton University’s Hereditary Cancer Center. He discovered the genetic condition, which is passed down through generations. People with Lynch Syndrome are at increased risk of colon and other types of cancer.
Researchers at UNMC are making strides in dealing with Her2.
Dr. Kay Wagner says Her2 is an aggressive type of breast cancer. He says there are several subsets and that each case must be treated differently.
Dr. Wagner says in previous studies, it was thought that by inhibiting a certain protein called Cyclin D1, the growth of breast cancer cells could be stopped or slowed. But he says his research indicated the opposite was true.